Stockwinners Market Radar for August 25, 2021 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:02 EDT Brookfield Infrastructure increases ownership in Inter Pipeline to 68.7% - Brookfield Infrastructure (BIP), together with its institutional partners, and Inter Pipeline (IPPLF) announce that Brookfield Infrastructure has successfully taken up and paid for the shares tendered as of August 20, 2021, bringing Brookfield Infrastructure's ownership of Inter Pipeline's common shares to 68.7%. With a controlling interest greater than 66 2/3% of the common shares of Inter Pipeline, Brookfield Infrastructure intends to pursue a privatization transaction to acquire any Inter Pipeline shares that are not tendered prior to the expiry of the mandatory extension of the Offer. Brookfield Infrastructure and Inter Pipeline are in discussions regarding a possible Subsequent Acquisition Transaction (as defined in the Offer) and intend to announce details of such a transaction at a later date. Completion of any such transaction is expected approximately 60 days from the expiry of the Offer.

18:23 EDT Salesforce CEO: We're more committed to expanding our margins than ever - Marc Benioff is speaking in an interview on CNBC's Mad Money.

17:47 EDT Fortinet CTO sells 80K share of common stock - In a regulatory filing, Fortinet disclosed that its co-founder and CTO Michael Xie sold 80K shares of common stock on August 24th in a total transaction size of $24.1M.

17:15 EDT Kopin CEO buys 50K shares of common stock - In a regulatory filing, Kopin disclosed that its CEO John Fan bought 50K shares of common stock on August 24th in a total transaction size of $272.5K.

17:09 EDT Four Corners Property Trust acquires O'Reilly Auto Parts property for $2.3M - Four Corners Property Trust announced the acquisition of an O'Reilly Auto Parts property for $2.3M. The property is located in a corridor in Illinois and is corporate-operated under a net lease with approximately five years of term remaining. The transaction was priced at a 6.5% capitalization rate, exclusive of transaction costs.

16:52 EDT Vaalco Energy signs LOI with World Carrier Offshore Services to provide FSO unit - Vaalco Energy announced that its affiliate Vaalco Gabon has signed a binding letter of intent, or LOI, with World Carrier Offshore Services to provide and operate a Floating Storage and Offloading, or FSO, unit at Vaalco's Etame Marin field offshore Gabon for up to eight years with additional option periods available upon the expiration of the current floating production, storage and offloading, or FPSO, contract in September 2022. The non-binding LOI with Omni Offshore Terminals, which Vaalco announced in April of this year, expired without any mutually agreeable contract being reached. Vaalco has studied several alternatives regarding the expiration of the contract on its current FPSO in September 2022. The proposed development approach utilizing an FSO with all processing on existing platforms aligns with Vaalco's ongoing strategy to reduce operating costs and extend field life. This is particularly attractive due to the potential for meaningful ongoing operating cost reductions over its term compared with the current FPSO arrangement and other options analyzed, as well as removing both the risk of life extension costs on the existing vessel. Once the field is reconfigured, the agreement with World Carrier to convert and operate the Cap Diamant is expected to lead to annual operating expense savings of around $20M to $25M gross over the life of the new agreement, resulting in a payback of its invested capital and enhanced margins going forward. Additionally, Vaalco continues to believe that the capital costs for the field reconfiguration and the upcoming planned 2021/2022 drilling campaign can be funded with cash from operations and cash on hand. George Maxwell, Vaalco's CEO, commented, "We are very pleased to finalize an agreement with World Carrier that will allow us to sustain our operational excellence and robust financial performance at Etame through 2030. Additionally, this new solution costs almost 50% less than the current FPSO solution and will reduce our overall costs by approximately 17% to 20%. Current total field level capital conversion estimates are $40 to $50 million gross ($26 to $32 million net to VAALCO) spread across 2021 and 2022. This capital investment is projected to save approximately $20 to $25 million gross per year ($13 to $16 million net to VAALCO) in operational costs through 2030, giving the project a very attractive payback period of only two to two and a half years. It is clear this is a very economical solution for VAALCO and should help us to enhance the profitability of our flagship asset at Etame and materially increase stakeholder returns. We expect to have the FSO in place and operating in September 2022 prior to when our current FPSO contract expires. We will continue to maximize the value opportunities for our shareholders and look forward to beginning our next drilling campaign at Etame later this year."

16:39 EDT Elastic jumps 5% to $165.75 after Q1 earnings beat

16:36 EDT Pure Storage jumps 8% to $22.70 after Q2 results, FY22 guidance beat estimates

16:34 EDT Williams-Sonoma jumps 13% to $193.10 after Q2 results beat, FY21 guidance raised

16:31 EDT Cyberoptics receives $1.7M of new orders for MX3000 inspection systems - CyberOptics has received new orders valued at $1.7M from a recurring customer for its MX3000 memory module inspection systems, powered by Multi-Reflection Suppression sensors. These final vision inspection systems are expected to be recognized as revenue in the first half of 2022.

16:31 EDT CVR Partners boosts cost view of turnaround at Coffeyville to $8M-$10M - CVR Partners announced that it currently intends to defer the scheduled turnaround at its Coffeyville, Kansas, nitrogen fertilizer facility from October 2021 to the third quarter of 2022. CVR Partners now expects its total forecasted turnaround spending for 2021 of approximately $8M to $10M of expense for the Coffeyville facility to be spent in 2022, which will be in addition to the planned 2022 turnaround for the Partnership's East Dubuque nitrogen fertilizer facility. "The health and safety of our employees, contractors and communities remains our critical priority," said Mark Pytosh, President and Chief Executive Officer of CVR Partners' general partner. "Between the recent spike in COVID-19 cases and the addition of Louisiana to Kansas' travel quarantine list, we thought it prudent to reconsider the timing of this turnaround.CVR Partners will continue to monitor its marketing and operating conditions and make adjustments, if needed, to its turnaround and maintenance planning

16:26 EDT Hexo holders approve Redecan deal, senior secured convertible note share reserve - HEXO announces that at its meeting of shareholders holders of common shares of HEXO "showed their overwhelming support of the previously announced acquisition of all of the outstanding shares of the entities that carry on the business of Redecan, Canada's largest privately-owned licensed producer in exchange for $400M to be paid in cash in addition to the issuance of 69,721,116 Common Shares (the "Consideration Shares", subject to certain customary adjustments. A total of 28,969,378 Common Shares were represented at the Meeting in person by virtual attendance or by proxy.

16:21 EDT Williams-Sonoma raises FY21 net revenue growth view to high-teens to low 20s - The company states: "Given the strength of our business year-to-date and the macro trends that we believe will continue to benefit our business, we are raising our fiscal year 2021 outlook to high-teens to low-twenties net revenue growth and non-GAAP operating margin between 16% to 17%."

16:20 EDT ABM to acquire Able Services for $830M, sees accretion - ABM announced that it has reached a definitive agreement to acquire Able Services, a facilities services company headquartered in San Francisco, in a cash transaction valued at $830M. The transaction is expected to close by the end of September, subject to approval under the Hart-Scott-Rodino Antitrust Act and other closing conditions. Founded in 1926, Able is the largest family-owned provider of building maintenance, engineering and facility operations in the United States, with revenues of $1.1B and adjusted EBITDA of $65M, normalized for COVID-19-related impacts. Engineering services represents approximately 60% of their total revenues, with janitorial services accounting for approximately 40%. Able's 80% unionized workforce provides facility services to over one billion square feet of real estate, strengthening ABM's national presence. ABM expects the transaction to be accretive to adjusted earnings per share immediately after closing. ABM expects to achieve approximately $30M to $40M in cost synergies, the majority of which are expected be realized within the first year following completion of the transaction.

16:18 EDT Williams-Sonoma raises quarterly dividend by 20% to 71c per share - The quarterly dividend is payable on November 26, 2021 to stockholders of record as of the close of business on October 22, 2021.

16:16 EDT Snowflake sees FY22 product revenue $1.06B-$1.07B, up 91%-93%

16:15 EDT Snowflake sees Q3 product revenue up 89%-92% at $280M-$285M

16:13 EDT Becton Dickinson's at-home COVID-19 test granted emergency use authorization - Becton Dickinson's BD Veritor At-Home COVID-19 Test has received an Emergency Use Authorization from the FDA, the first at-home COVID-19 rapid antigen test to use computer vision technology in a smartphone to interpret and provide a digital display of testing results. BD developed this new digitally read, lateral flow antigen self-test to make COVID-19 testing faster and easier for people to complete in their own homes. The test will initially be made available to businesses, schools and governments. The BD Veritor At-Home COVID-19 Test will use a nasal swab and a mobile app from Scanwell Health that yields test results in 15 minutes.

16:12 EDT Salesforce jumps 3% to $268.69 following Q2 beat, raised outlook

16:10 EDT Bioventus invests in Trice Medical minimally invasive technologies - Bioventus has completed a strategic investment in Trice Medical . In conjunction with Bioventus leading the Series D funding round, the Company will receive exclusive sales and distribution rights to Trice's products outside of the US. Bioventus and Trice have also agreed to enter into a co-development arrangement to explore the integration of Trice technologies with Bioventus' current and future peripheral nerve stimulation ("PNS") offerings of StimRouter and TalisMann in order to accelerate adoption of both companies' products. Trice, founded in 2011 and based in Malvern, Pennsylvania, combines their handheld arthroscope and portable ultrasound visualization technologies with the company's differentiated surgical devices to treat a range of sports medicine and orthopedic conditions, including tendinopathy, planter fasciitis and carpel tunnel, in order to improve patient recovery time, reduce pain, minimize scarring and move surgical procedures out of higher cost points of care.

16:08 EDT Tortoise Acquisition Corp. II announces shareholder approval for Volta deal - Tortoise Acquisition Corp. II (SNPR) announced that its shareholders voted to approve the previously announced business combination with Volta Industries (VLTA) and all other proposals presented at TortoiseCorp II's extraordinary general meeting of shareholders held on August 25.

16:06 EDT Splunk rallies 4% to $161.00 after Q2 revenue beat

16:04 EDT Amneal Pharmaceuticals announces phase 3 clinical trial data for IPX-203 in PD - Amneal Pharmaceuticals "announced positive topline results from the pivotal Phase 3 RISE-PD clinical trial that evaluated the novel formulation, IPX-203, in patients with Parkinson's disease (PD) who have motor fluctuations. The trial met its primary endpoint, demonstrating superior "Good On" time from baseline in hours per day at the end of the 13-week double-blind treatment period with IPX-203 CD/LD extended-release capsules compared with immediate-release CD/LD. Based on these topline results plus other supportive data, Amneal plans to submit a New Drug Application for IPX-203 with the FDA in mid-2022. Phase 3 topline results showed the study was successful in demonstrating statistically significant improvement in efficacy for IPX-203 compared to immediate-release CD/LD, even when IPX-203 was dosed on average 3 times per day and immediate-release CD/LD was dosed on average 5 times per day. IPX-203 treatment resulted in 0.53 more hours of "Good On" time than immediate-release CD/LD, when comparing change from baseline in both study arms. "

16:03 EDT Fox Corp. invests in Eluvio - Fox Corporation has made a strategic investment in Eluvio to accelerate the adoption of Eluvio's platform across the broader media and entertainment industry. Eluvio will provide the underlying technology platform for Blockchain Creative Labs, FOX Entertainment's and Bento Box Entertainment's recently launched NFT business and creative unit. Paul Cheesbrough, Chief Technology Officer and President of Digital for Fox Corporation, will also join Eluvio's Board of Directors. Launched in 2019, Eluvio is led by Emmy Award-winning technologists, Michelle Munson and Serban Simu, and the company's Eluvio Content Fabric is an open protocol blockchain network built for owner-controlled storage, distribution, and monetization of digital content at scale. Eluvio LIVE, powered by the Eluvio Content Fabric, is a multi-tenant turnkey platform for publishers that provides 4K streaming and ticketing of events with media marketplaces. Fox Corporation's investment marks the completion of Eluvio's Series A round at a valuation of $100M.

16:02 EDT Analog Devices raises share buyback by $8.5B - Analog Devices announced that the Board of Directors authorized the company to repurchase an additional $8.5B of its common stock. This brings the total remaining authorization to approximately $10B. ADI expects to fund the repurchases through cash generation from operations as well as cash from the closing of the Maxim Integrated acquisition.

15:57 EDT Vertex announces Canadian Marketing Authorization for Kalydeco - Vertex Pharmaceuticals announced that Health Canada has granted Marketing Authorization for Kalydeco for use in children with cystic fibrosis as young as four months of age who have at least one of the following gating mutations in their cystic fibrosis transmembrane conductance regulator gene. "With today's approval, children in Canada as young as 4 months now have a medicine to treat the underlying cause of their disease," said Nia Tatsis, Executive Vice President and Chief Regulatory and Quality Officer, Vertex.

15:53 EDT Avangrid says all 24 intervenors support or don't oppose PNM merger - Avangrid (AGR) and PNM Resources (PNM) announced additional support for the stipulation agreement in the New Mexico Public Regulation Commission proceeding to review the merger between the two companies. Almost all of the 24 intervenors in the case have signed on to the stipulation agreement or confirmed that they either support or do not oppose the merger, the companies said in a statement. Said Dennis Arriola, CEO of Avangrid: "The progress we have made to gain this nearly unanimous stakeholder support for this merger is not something we take for granted and we look forward to continuing this process toward the successful culmination of this transaction which will bring significant benefits to the people of New Mexico."

15:25 EDT Takeda halts distribution of 1.63M Moderna doses over 'foreign matter' - Takeda Pharmaceutical (TAK), the distributor of Moderna's (MRNA) Covid-19 vaccine in Japan, announced its decision to halt the use of three lots, or 1.63M doses, of the shot after receiving multiple reports of "foreign matter" inside some unused vials. Takeda has asked Moderna to investigate the contaminants found in the three lots. The probe is ongoing and there have been no reports that the affected lots have caused safety issues, the company said in a statement. Reference Link

14:32 EDT Air Canada mandates all employees get COVID-19 vaccine - Air Canada said it has introduced a new health and safety policy to further protect employees and customers that makes it mandatory for all employees of the airline to be fully vaccinated against COVID-19 and to report their vaccination status as of October 30. In addition, the airline is making full vaccination a condition of employment for any individual hired by the company. Under the mandatory vaccination policy, testing will not be offered as an alternative. While Air Canada will fulfill its duties to accommodate employees who for valid reasons, such as medical conditions, cannot be vaccinated, failure to be fully vaccinated by October 30 will have consequences up to and including unpaid leave or termination, except for those who qualify for accommodation.

14:27 EDT Walmart DSP to be unveiled by end of October - According to an earlier blog post from Rich Lehrfeld, Senior Vice President, Walmart Connect: "Walmart announced announced earlier this year a new name for our media business, Walmart Connect, in an effort to reflect our new focus and strategic vision. With this new name and vision, we wanted to emphasize our commitment to connecting brands and our more than 150 million weekly customers at scale using innovative ad solutions. Our vision is focused on three key strategic areas that allow us to go beyond traditional media channels and offer meaningful experiences and integrations to bring brands measurably closer to their customers. First, we are growing our offerings across our digital properties to provide more holistic ad campaigns. Second, we are introducing new omni capabilities to help brands reach customers in our stores. And today, we are expanding our offsite media opportunities at scale by introducing our new demand-side platform, Walmart DSP. Walmart DSP is a first-of-its kind demand-side platform that was built in partnership with the world's leading independent DSP, The Trade Desk. As the world's leading retailer, we are thrilled to be partnering with such a prominent figure in the adtech space to pioneer a new frontier in digital advertising and give advertisers an open, transparent and objective platform while upholding privacy standards Walmart DSP will be available for select suppliers by the end of October, just in time for the holiday shopping season." Reference Link

12:48 EDT Princess: Island Princess, Diamond Princess to return to service in spring 2022 - Princess Cruises is announcing updated restart timing for Island Princess and Diamond Princess. Island Princess will now return to service with a series of cruises to the Caribbean in spring 2022, prior to its 14-day Panama Canal Ocean to Ocean voyage on April 27, 2022. Diamond Princess will also return to service in spring 2022 with a season of Japan sailings. Details of both new programs will be announced shortly. Island Princess and Diamond Princess join eight MedallionClass ships - Majestic Princess, Grand Princess, Ruby Princess, Enchanted Princess, Sky Princess, Regal Princess, Caribbean Princess and Emerald Princess-which have returned to service or are scheduled to restart by November 28, 2021, taking guests to Alaska, the Caribbean, Panama Canal, Mexico, Hawaii, and the California Coast. As a result of these changes, Princess Cruises is cancelling its 2021-2022 South America & Antarctica Program on Diamond Princess, and its 2022 World Cruise along with two December 2021 Island Princess cruises.

12:42 EDT Watchdog finds 'major weaknesses' in Apple's App Store child safety measures - Non-profit watchdog group Campaign for Accountability on Wednesday released a report revealing "major weaknesses" in Apple's App Store child safety measures that allow minors to easily access adult content such as pornography and gambling. As part of its Tech Transparency Project, the watchdog group said it set up an Apple ID for a fictitious 14-year-old user and used it to download and test 75 apps in the App Store across several adult-oriented genres, and the investigation found than the underage user could easily evade the apps' age restrictions. Reference Link

12:13 EDT Deere raises quarterly dividend 17% to $1.05 per share - The Deere & Company board of directors declared an increased quarterly dividend of $1.05 per share on the company's common stock. The dividend is payable November 8, 2021, to stockholders of record on September 30, 2021.The new quarterly rate represents an additional 15c per share over the previous level - an increase of approximately 17%. "The latest increase in our quarterly dividend is a reflection of Deere's recent strong performance and the success of our new strategy and operating model," said John C. May, chairman and CEO. "It also shows our confidence in the company's future direction."

12:09 EDT Infosys to establish digital development center in Mississauga - Infosys announced that it will establish a new digital development centre at its largest Canadian office in Mississauga. This is aimed at creating 500 high quality jobs in the Toronto Region over the next three years. Spanning nearly 50,000 square feet and bringing significant investment from Infosys to the country, this digital development centre will train, upskill, and reskill employees in the technologies needed to help Canadian businesses accelerate their digital transformation. It will also enable Infosys to better collaborate with clients to develop cross-functional solutions to pressing business challenges. Infosys, in the Toronto Region, currently serves businesses in the financial services, healthcare, communications, retail, and natural resources sectors. Artificial intelligence, data science, automation, and machine learning are the core capabilities that this centre would nurture and expand. In response to surging demand for training, re-skilling, and learning by employers, Infosys previously committed to double its Canadian workforce to 4,000 employees by 2023. The digital development centre will play a key role in this expansion and lead the building of digital capabilities and training for the next generation of IT talent to support Canadian businesses.

12:00 EDT Wheels Up falls -14.1% - Wheels Up is down -14.1%, or -$1.12 to $6.80.

12:00 EDT Nordstrom falls -16.5% - Nordstrom is down -16.5%, or -$6.24 to $31.57.

12:00 EDT Olo rises 10.5% - Olo is up 10.5%, or $4.03 to $42.41.

11:56 EDT Ascendis Pharma trading halted, news pending

11:53 EDT Antelope enters licensing contract with Chengdu Baishengtong - China Ceramics, a Chinese manufacturer of ceramic tiles, announced that its newly-formed wholly-owned subsidiary which focuses on software development, Antelope Holdings, has entered into a licensing contract with Chengdu Baishengtong Business Consulting. The total fee to be paid to the company under the contract is approximately $900,000, of which 40% is to be paid within six months of the contract's execution and the remaining balance between six months and twelve months of the one-year contract term. Shares of Antelope Enterprise Holdings are up 10% to $3.31 in midday trading. Reference Link

11:01 EDT Target names Sarah Travis as president of Roundel - Target Corporation (TGT) named Sarah Travis president of Roundel, the retailer's in-house media company. Travis joins the company Sept. 13, and will report to Cara Sylvester, Target's executive vice president and chief marketing and digital officer. Travis was previously managing director of retail at Google (GOOGL).

10:05 EDT Rafael completes Phase 1b trial of CPI-613, initiates Phase 2 - Rafael Pharmaceuticals announced the completion of a Phase 1b clinical trial of CPI-613 in combination with gemcitabine and cisplatin in patients with biliary tract cancer. In collaboration with Michigan Medicine, the Phase 1b study consisted of a multicenter trial of gemcitabine and cisplatin with devimistat as first-line therapy for patients with locally advanced unresectable or metastatic biliary tract cancer who have had no prior treatment. "The Phase 1b part of the trial has successfully identified the recommended Phase 2 dose of CPI-613 when given in combination with gemcitabine and cisplatin in this patient population. The 2:1 randomized Phase 2 part of the trial has already started enrolling patients and will now determine the efficacy of devimistat at this maximum tolerated dose in combination with gemcitabine and cisplatin as compared with the combination chemotherapy alone" said Dr. Vaibhav Sahai, MBBS, M.S., primary investigator and medical oncologist at the University of Michigan Rogel Cancer Center in Ann Arbor, Michigan. An estimated 68 to 78 patients will be enrolled in the study. .

10:02 EDT Navistar International appoints Mathias Carlbaum as new CEO - The Navistar Board of Directors has appointed Mathias Carlbaum as the new CEO and President of Navistar International effective September 1. He will succeed Persio Lisboa, who has held this position since July 2020. In his 35 year-long tenure with the company and particularly in his recent roles as COO and CEO, Persio Lisboa was instrumental in returning Navistar to profitability and launching and executing a solid strategy called Navistar 4.0. After a short transition phase, Lisboa will retire. Until the end of March 2021, Mathias Carlbaum was Executive Vice President Commercial Operations at Scania CV AB. After a long management career at Scania, he has extensive experience in sales and international markets. Since April 2021, he has been leading the post-merger management of Navistar on behalf of the TRATON GROUP.

10:00 EDT Wheels Up falls -10.9% - Wheels Up is down -10.9%, or -86c to $7.06.

10:00 EDT Nordstrom falls -15.5% - Nordstrom is down -15.5%, or -$5.85 to $31.96.

10:00 EDT N-able rises 7.6% - N-able is up 7.6%, or 98c to $13.90.

09:59 EDT Willis Towers Watson enters initial, non-binding agreement to acquire Leaderim - Willis Towers Watson announced that it has entered into an initial, non-binding agreement to acquire Leaderim, an insurance broking and consultancy business in Israel. Leaderim is one of the leading insurance brokers in Israel and was established over 20 years ago. Its team of 45 professionals offers a broad range of commercial insurance solutions to the Israeli market. It also has significant experience in creating multinational risk programs, reflecting the large concentration of global companies operating in Israel. This announcement signals that the two parties have signed heads of terms and will now move towards completing the acquisition. Any transaction would be subject to completion of definitive agreements, and legal and regulatory approvals.

09:47 EDT Zhangmen Education falls -6.5% - Zhangmen Education is down -6.5%, or -22c to $3.15.

09:47 EDT Univar rises 4.8% - Univar is up 4.8%, or $1.11 to $24.23.

09:47 EDT Dick's Sporting rises 15.8% - Dick's Sporting is up 15.8%, or $18.06 to $132.45.

09:36 EDT Facebook Messenger announces new features, including 'Soundmoji' - Facebook's Loredana Crisan, Vice President of Messaging Products, Messenger, said in a statement: This month we're celebrating Messenger's 10th birthday! Today, we're introducing Poll Games on Messenger... In the US, we're introducing a new way to receive cash gifts directly through Messenger. When a friend sends you a cash gift for your birthday, you'll be notified on Messenger and Facebook with their gift message wrapped and accompanied by virtual balloons. Once you confirm your Facebook Pay details, the cash gift will be instantly deposited into your bank account. You can also send a catchy birthday song Soundmoji and use a Message Effect to add a burst of confetti to your celebratory message or even wrap it up with a bow... We're introducing a new way for you to easily share Facebook contacts with friends through Messenger. Simply select the contact you want to share, access the chat settings and tap Share Contact under the More Actions section." Reference Link

09:32 EDT AT&T awarded task order from DOS worth up to $609M - AT&T was awarded an agreement from the U.S. Department of State to provide "turnkey" telecommunications solutions and support to the DOS's more than 270 diplomatic posts and operations sites worldwide. The agreement is valued at up to a maximum of $609M over five years if all options are exercised.

09:16 EDT Matterport announces open beta launch of Notes collaboration tool - Matterport announced the open beta launch of Notes, a conversational, real-time team collaboration, communication and file sharing tool directly inside Matterport digital twins. With Notes, home buyers and renters can invite friends and family to visually locate and tag their favorite rooms and features of a property; corporate teams in the workplace can collaborate on space planning and office layouts; and enterprise organizations can manage facilities, assign tasks, and make key operating decisions across a portfolio of remote locations faster.

09:13 EDT AIM ImmunoTech announces filing of provisional patent application for Ampligen - AIM ImmunoTech provided an update on the company's efforts to develop its drug Ampligen as a potential intranasal therapeutic for COVID-19, including the announcement of a new provisional patent application for Ampligen as both an intranasal and an intravenous therapy for what AIM describes as Post-COVID-19 Cognitive Dysfunction. AIM has been working steadily to expand its COVID-19 patent portfolio. In addition to the new provisional patent application addressing compositions and methods for treating PCCD, in February 2020 the company filed multiple COVID-19-related provisional patient applications, which are now patent pending worldwide, for Ampligen as a COVID-19 therapy and as a vaccine adjuvant. Early data has demonstrated that patients with symptoms of PCCD being treated with Ampligen in the ongoing AMP-511 Early Access Program have reported improvements in cognitive function, according to Charles Lapp, MD, at Hunter-Hopkins Center in Charlotte, N.C. "There is a growing and significant need for effective therapies to treat COVID-19, both in the acute phase and its longer-term effects," said AIM CEO Thomas Equels. "We believe that Ampligen has the potential to activate the body's innate immune system to fight COVID-19 through its use as a front-line, early-onset therapeutic - which includes potentially reducing intranasal viral load, potentially curbing the spread of the disease and lessening its severity. We believe Ampligen also can play a role in treating Post-COVID-19 Cognitive Dysfunction."

09:11 EDT STMicroelectronics, Xilinx collaborate to power radiation-hardened FPGAs - STMicroelectronics (STM) announced it is collaborating with Xilinx (XLNX) to build a power solution for the Xilinx Kintex UltraScale XQRKU060 radiation-tolerant FPGA, leveraging QML-V qualified voltage regulators from ST's space-products portfolio. "The programmability of the Xilinx XQRKU060 revolutionizes the economics of equipment like space-research instruments and commercial satellites. The device delivers a combination of high compute density and integration that historically required an application-specific IC, which typically involves custom design with associated engineering expenses and turnaround time," the company said. ST worked closely with Xilinx to design a power source that ensures reliable operation of the XQRKU060 by providing fixed-point voltage accuracy as well as stability in the event of transients due to normal FPGA operation and radiation events. The solution uses ST's RHRPMPOL01 rad-hard point of load 7A monolithic synchronous step-down regulator and RHFL6000A linear voltage regulator, all SEL immune and QML-V qualified. These devices meet the requirement for an input voltage up to 12V and output voltage down to 0.8V. Both exhibit high fixed-point accuracy with radiation performance that ensures high resistance to Total Ionizing Dose thereby minimizing any output-voltage drift.

09:09 EDT Fortinet announces initiatives as part of upcoming Fortinet Championship - Fortinet announced several initiatives as part of the upcoming Fortinet Championship. This premier event will kickoff the 2021-22 PGA TOUR Season and will be held in Napa, California at the Silverado Resort and Spa, September 13-19, 2021. Further to its mission to securepeople, devices, and dataeverywhere, Fortinet will bring together the world's best golfers and technology leaders, including its community of customers and partners, in one forum to discuss the latest security innovations and networking trends.

09:08 EDT Kelso Technologies announces regulatory completion of new truck tanker equipment - Kelso Technologies reports that the company has completed the design, engineering and required regulatory testing of two key pieces of truck tanker equipment created for the reliable containment and pressure management of commodities that are transported via roads. The specialized products include a combined pressure/vacuum relief valve and a one-bolt manway. These new products are based on our existing patents that are utilized in rail tank car applications and meet all DOT 407 49 CFR 178.345 regulations. The Company believes that Kelso has reached the key milestone of approval of the PVR and OBM design with the trucking industry setting the stage for potential full market adoption. During the development process several prototypes of the PVR and OBM were installed on a truck tanker for design assessment and testing by the Company's industrial technology partner. After design completion, the OBM and PVR were fully field-tested and successfully vetted at a third party laboratory to ensure both products met or exceeded the established requirements and they are now ready for full market distribution. The Company has commenced marketing and sales initiatives to promote wide scale adoption of the truck tanker OBM and PVR. Management believes that these new product entries can lead to new multi-million-dollar revenue opportunities from truck tanker markets. James Bond, CEO of the company comments that: "Despite frustrating time delays and scheduling interruptions imposed by pandemic circumstances, the Company's relationships continued to grow with an increased number of strategic product development stakeholders. This has allowed Kelso to maintain the development of its brand through the creation of new technology solutions for transportation operations in rail, road and wilderness transportation markets. The successful completion of the regulatory qualified truck tanker PVR and OBM are key examples of the benefits of our commitment to research and development of unique products targeting previously untapped revenue opportunities. Management continues its research and development initiatives based on specific stakeholders' design needs and engineering input which have proven to be very effective and efficient strategically. Over time the objective is to expand financial growth and performance from sales from a growing portfolio of regulatory compliant products servicing a wider range of transportation markets."

09:07 EDT Conduent publishes 2020 Corporate Social Responsibility Report - Conduent published its 2020 Corporate Social Responsibility report, which outlines the company's ongoing commitment to conduct business ethically, responsibly, and sustainably, while continuing to advance its progress in key Environmental, Social and Governance areas. The 2020 Conduent CSR report highlights a number of those commitments and initiatives, including: Environmental: Reduced real estate footprint by over 50% over the past three years and implemented recycling and waste management programs across our facilities; Reduced Scope 2 CO2 emissions by 23% Year over Year; Recycled more than 53 million pounds of paper-based items since 2017 while transitioning end users to digital communications. Social: Named a new head of Diversity and Inclusion to the senior leadership team who has driven multiple initiatives including a 65% expansion of employee impact groups; Augmented the Conduent Associate experience with a focus on creating an environment for associates to be themselves, thrive and make a difference; Extended associate wellness benefits, implemented virtual training and created additional opportunities for engagement with leadership. Governance and Ethics: Expanded awareness of global Ethics Program that promotes and instills a culture of integrity and honesty, including mandatory code of conduct training; Maintained availability of global 24/7 ethics helpline for associates, partners and others; Ongoing transparency and reporting on ESG topics including disclosure of ESG data aligned with SASB Framework; Additional steps taken by Conduent noted in the CSR report include: the creation through the company's Board of Directors of a Corporate Social Responsibility and Public Policy Committee, the review and revision of corporate policies to better reflect ESG goals, and the enhanced disclosure of ESG metrics and measurement. Conduent's commitments align with five of the United Nations' Sustainable Development Goals that support the communities where its associates live and work: No Poverty; Zero Hunger; Good Health and Wellbeing; Sustainable Cities and Communities; Decent Work and Economic Growth.

09:04 EDT Nokia selected by Union Wireless to modernize Radio Access Network - Nokia announced it has been selected by Union Wireless to swap out its existing RAN equipment with Nokia's AirScale 4G/5G radio portfolio to modernize its network while supporting the Secure and Trusted Telecommunications Act. Union Wireless will deploy 4G service initially with a built-in path to 5G for its subscribers. In addition to supplying radios, Nokia is providing all deployment and integration services including ground and tower work, installation, commissioning, and RF design and cluster optimization.

09:03 EDT Missfresh's sales on JD.com's platforms up by 389% since April - Missfresh (MF) has seen a 389% increase in its sales on JD.com (JD) and JD-Daojia since commencing its collaboration with JDDJ in April this year. Currently, approximately 570 of Missfresh's Distributed Mini Warehouses sell on JDDJ, in 17 cities. In April this year, Missfresh began to sell goods on JDDJ, JD.com's affiliate platform, through the "Omnichannel Fulfillment Program". This enables consumers to order from Missfresh's nearby warehouses through JDDJ's app. The products offered include fruits, vegetables, seafood, grains, ready-to-cook meals, and more.

09:02 EDT PagerDuty appoints Roshan Kindred as chief diversity officer - PagerDuty announced it has appointed Roshan Kindred to the newly created position of chief diversity officer. Kindred is responsible for amplifying PagerDuty's inclusion, diversity and equity initiatives, and is a strategic new member of the company's executive leadership team. In addition, as international revenue increased by 38% year over year in its first quarter, PagerDuty also announced Jill Brennan will join PagerDuty as vice president, EMEA to continue to expand the company's global reach. Kindred joins PagerDuty with more than 20 years of experience in customer experience, business and ID&E strategies. Most recently, Kindred was the chief diversity officer and principal at InSeason Development Group

08:58 EDT Support.com jumps 18% to $13.80 in pre-market trading - Shares of Support.com are up 19% at $13.80 in pre-market trading following yesterday's 4.5% advance. The stock is the third-highest trending ticker on StockTwits in terms of message volume this morning.

08:40 EDT BOSS Revolution Money, PRISM Transfer partner for payout options in Haiti - BOSS Revolution Money has partnered with PRISM Transfer to significantly expand payout options in Haiti. The partnership provides BOSS Revolution customers with more disbursement options when sending cash to friends, family and loved ones in Haiti following the earthquake and subsequent flooding from Tropical Storm Grace. With this collaboration, PRISM Transfer customers can immediately collect remittances at Fonkoze locations and MonCash customers can authorize PRISM Transfer to deposit remittances directly to their mobile wallets when receiving remittances via BOSS Revolution. Through August 31, 2021, BOSS Revolution remittances up to $150 to MonCash full registered wallets and Fonkoze office locations throughout Haiti are just $1.00 when initiated from the BOSS Revolution Money app or website using a debit card, and start at $5.00 when initiated through a BOSS Revolution Money retail agent. Customers initiating remittances through retail agents receive $1.00 off when using the promo code HAITI1 through September 30, 2021.

08:38 EDT NextPlay Technologies to acquire 100% of assets of Token IQ, terms not disclosed - NextPlay Technologies has entered into a definitive agreement to acquire 100% of the assets of Token IQ, an innovator in digital asset management with its smart compliant token technology. The company said, "Token IQ has many unique capabilities, but its greatest attributes are its ability to afford cryptocurrency owners a solution to replace their assets should they lose access to, or control of, their assets and its handling of "Know Your Customer" issues -- solving many key regulatory requirements. NextPlay will not only look to license the IP, but also plans to integrate the service into its wholly owned Bank -- NextBank International to better serve its cryptocurrency customers." One of the primary issues associated with crypto investing is the existential custody risk associated with the loss of passwords or wallet seeds, resulting in the inability to access assets. A critical function of Token IQ is the ability to allow issuers to manage this risk across public distributed ledgers -- a key solution needed by any cryptocurrency owner, and a technology that we anticipate will become a cornerstone for all of our NextBank and Longroot coin offerings. This patent-pending technology also allows issuers to control the flow of tokens. The Token IQ technology can be invaluable in the enforcement of "Know Your Customer" and other regulatory requirements which is a sensitive area that regulators around the world are increasingly focused on. The platform also supports vesting, lockups and asset freezing, which can enhance market making and liquidity while also reducing risks around custodianship, inheritance, and other legal circumstances related to proper asset disposition. We plan to pursue patents for this proprietary technology in key markets around the world. The Token IQ foundational IP is designed to reconcile legal and regulatory requirements around digital assets, including KYC, Anti-money laundering and shareholder rights enforcement, all common pain points within the crypto markets today. It has been designed to do so across a distributed ledger, including Ethereum and Stellar. The acquisition of Token IQ is subject to certain closing conditions, including the approval of NextPlay's shareholders.

08:36 EDT Raymond James announces 3-for-2 stock split, declares quarterly dividend - On August 24, 2021, the Board of Directors of Raymond James Financial approved a 3-for-2 common stock split, effected in the form of a 50% stock dividend, payable September 21, 2021 to shareholders of record on September 9, 2021. Shareholders of record at the close of business on September 9, 2021 will receive one additional share of Raymond James Financial common stock for every two shares owned. These additional shares will be distributed beginning September 21, 2021. Cash will be distributed in lieu of fractional shares based on the closing price on the NYSE on September 20, 2021. On August 24, 2021, the Board of Directors also declared a quarterly cash dividend on shares of its post-split common stock of $0.26 per share, which is economically equivalent to the pre-split amount of $0.39 per share paid in the preceding quarter. The cash dividend is payable on October 15, 2021 to shareholders of record on October 1, 2021.

08:35 EDT 17EdTech: Compliance with Shanghai Measures will have 'material adverse' impact - 17 Education & Technology announced that the Shanghai local government issued the "Measures to Further Alleviate the Burden of Homework and After-School Tutoring on Students in Compulsory Education" and answers to twelve questions related to such measures on August 24, 2021. The Shanghai Measures were adopted to implement the Opinions on Further Alleviating the Burden of Homework and After-School Tutoring on Students in Compulsory Education, published in July 2021 by the General Office of the CPC Central Committee and the General Office of the State Council of the PRC, and aim to, within one year, " effectively control the volume of, and the amount of time it takes to complete, homework assigned to students during the compulsory education stage, ensure all compulsory education schools provide on-campus, after-school services, complete the rectification of business practices of online and offline providers of after-school tutoring services on academic subjects in China's compulsory education system, effectively reduce the excessive burden upon students from school homework and after-school tutoring, the education expenditures from their families and the burden on their parents' energy." With respect to homework assignment and after-school tutoring services, among other things, the Shanghai Measures contain the following provisions: Schools are prohibited from assigning homework to first- and second-graders, assigning written homework that takes longer than 60 minutes on average to complete to third-, fourth- or fifth-graders, or assigning written homework that takes longer than 90 minutes on average to complete to students in junior high-school. Previously registered online Academic AST providers will be subject to a new round of approval process. After-school tutoring providers are strictly prohibited from providing Academic AST during any national holiday, weekend, winter and summer break period; Online Academic AST classes cannot be offered after 9:00 p.m. during weekdays, and each class session cannot last longer than 30 minutes, with mandatory recessions of not less than 10 minutes between classes. Academic AST providers are prohibited from offering classes over contents outside of or in advance of the school curriculum, offering classes based on any foreign curriculum, soliciting and recruiting school teachers by offering excessive compensation, or employing foreign personnel to carry out training activities from overseas. Non-Academic AST providers are prohibited from offering Academic AST classes. Prices for Academic AST will need to follow the guidelines from the government. Academic AST providers are prohibited from financing by way of publicly listing its securities; listed companies may not invest in Academic AST providers through capital markets fundraising activities, and may not acquire assets of Academic AST providers; and foreign capital is prohibited from controlling or participating in Academic AST providers. Enhancing oversight of AST advertising, including restricting the channels for deploying AST advertisements. Institutions providing after-school tutoring services on academic subjects in high schools will be supervised with reference to the Shanghai Measures. Academic AST providers are strictly prohibited from recommending or inducing students to use consumer loan products to pay training fees. The Company's compliance with the Shanghai Measures will have a material adverse impact on its business, results of operations and financial condition. In compliance with the Shanghai Measures, the Company has stopped and will stop offering online Academic AST classes over weekends, national holidays and school break periods.

08:33 EDT Mawson Infrastructure appoints Craig Hibbard as Chief Development Officer, - Mawson Infrastructure announces it has appointed Craig Hibbard as Chief Development Officer, CDO. Craig has over 15 years' experience in senior executive roles across property, development and real estate sectors in Australia, having worked at Iris Capital, Property Partnership Australia and Merivale respectively. Craig was previously responsible for the roll out of major projects including the development of Newcastle CBD's East End, multiple mixed use and land subdivision sites along with an extensive asset portfolio recapitalization program, cumulatively valued at over $700million, and at Mawson will be responsible for project deployment across the US and Australian facilities.

08:32 EDT Turnium announces onboarding of SD-WAN Edge Solution to IBM Cloud - Victory Square Technologies(VSQTF) is pleased to announce that its portfolio company Turnium Technology Group is collaborating with IBM (IBM) to onboard its cloud-native SD-WAN edge solution to IBM Cloud for Telecommunications. Turnium's solution is designed to help connect customers, applications and devices by creating a new cloud extension service that helps customers to interconnect their offices, vehicles, and devices sites with IBM Cloud in a single private international network. This brings Turnium closer to realizing its vision to Connect Everything, Anywhere.

08:25 EDT Ace Global Business Acquisition Ltd trading halted, news pending

08:17 EDT Sunrun launches PowerU employee education program - Sunrun launched PowerU, a new fully-funded employee education and upskilling program designed to train and develop its workforce for the rapidly growing clean energy industry. Through PowerU, Sunrun will nurture the next generation of green careers and professionals. The solar industry is currently on a trajectory to reach 400,000 jobs by 2030, but more than 900,000 skilled workers will be needed to reach President Joe Biden's 2035 clean energy target. The U.S. Department of Labor's Bureau of Labor Statistics predicts the solar installer will be the third fastest-growing job in America over the next decade. Sunrun has partnered with Guild Education to help meet this demand and connect employees to opportunities for advancement by providing access to 150+ fully-funded and flexible education and upskilling programs.

08:16 EDT authID.ai announces integration of CU NextGen with IDaaS platform - authID.ai announced that CU NextGen has integrated with its Identity as a Service platform. CU NextGen is a CUSO dedicated to delivering leading-edge and customizable technology and support to more than 40 credit unions across the United States, ensuring deeper and lasting relationships with employees, members, and communities. Through this new partnership, CU NextGen has begun roll-out of authID's identity services with its first credit union with plans for further expansion to additional credit unions across the United States. CU NextGen is leveraging authID's biometric identity authentication solution to transform the way its credit union clients recognize their members-both digitally and in-person, with similar, consistent experiences.

08:14 EDT American Resources picked by DOE to aid in assessment of rare earth elements - American Resources announced that the Company has been named to a U.S. Department of Energy Federal Demonstration Partnership award for the sorting for critical mineral-rich coal resource feedstock in a support role. Under the agreement, American Resources will provide support to the DOE sponsored program lead by Microbeam Technologies and Energy Technologies to determine novel methods for predicting rare earth elements and critical minerals in different coal types utilizing prompt gamma neutron activation analysis spectra technology.

08:11 EDT Parkit Enterprise to acquire Ottawa property for C$13.25M - PARKIT ENTERPRISE announced that it has agreed to acquire a class A industrial property in Ottawa Parkit has entered into an asset purchase agreement, with an arms length vendor, pursuant to which Parkit has agreed to acquire a property in Ottawa, Ontario for an aggregate purchase price of $13,250,000, subject to customary adjustments It is anticipated that the Acquisition will be completed on or before October 15, 2021. The Property is approximately 75,000 square feet of multi-tenanted light industrial space on approximately 4 acres of land. The Property is consistent with our philosophy of focusing on specific geographies. The purchase of the Property for $13,250,000, subject to standard adjustments, will be satisfied through funds on hand. The obligations of Parkit to complete the Acquisition is subject to conditions including, but not limited to: satisfactory due diligence and satisfactory environmental site assessment reports. The obligations of both Parkit and the Vendor to complete the closing of the Acquisition are subject to the satisfaction of other customary closing conditions.

08:10 EDT ManTech wins $86M contract with Department of Homeland Security - ManTech has been awarded an $86M contract by the Department of Homeland Security to provide U.S. Citizenship and Immigration Services with advanced architecture and engineering and analytic services. The scope of this five-year hybrid contract spans IT management oversight and an array of sophisticated solutions to build on and expand the capabilities of USCIS's legacy SPEDI. "This initiative will deliver end-to-end IT transformation that meets current needs and ensures the flexibility to grow and evolve with the mission," said Bryce Pippert, General Manager of ManTech's Federal Civilian sector. "By developing and deploying intelligent platforms that put Analytics, Automation and AI, Intelligent Systems Engineering, and cloud engineering to work in the here and now, we are equipping our customers for the future."

08:09 EDT Arcutis Biotherapeutics enroll first patient in Phase 3 trial of ARQ-154 - Arcutis Biotherapeutics announced it had enrolled the first patient in its single Phase 3 clinical trial evaluating topical roflumilast foam as a potential treatment for scalp and body psoriasis. Roflumilast foam is a once-daily topical foam formulation of roflumilast, a highly potent and selective phosphodiesterase type 4 inhibitor, which the company is developing for both seborrheic dermatitis and scalp and body psoriasis. The "A Randomized tRial Employing topiCal roflumilasT foam to treat scalp psORiasis" study is a parallel group, double blind, vehicle-controlled pivotal Phase 3 study of the safety and efficacy of ARQ-154 0.3% foam or a matching vehicle administered once-daily in approximately 420 subjects with scalp and body psoriasis ages 12 and older. The co-primary endpoints of the study include the proportion of subjects achieving Scalp-Investigator's Global Assessment success and the proportion of subjects achieving Body-IGA success, with IGA success defined as an IGA score of 'clear' or 'almost clear' plus a 2-point improvement from baseline after eight weeks. Based on prior discussions with the U.S. Food and Drug Administration, the Company believes that, if successful, this trial will provide sufficient basis to file a supplemental NDA for ARQ-154 in scalp and body psoriasis. "Our aim at Arcutis is to rapidly innovate topical treatments for dermatological conditions where there has been little to no treatment advances for decades. The initiation of our Phase 3 trial of roflumilast foam for scalp and body psoriasis is an important step forward to addressing an urgent unmet need," said Frank Watanabe, President and Chief Executive Officer at Arcutis. "The initiation of our ARRECTOR trial is the third of three new Phase 3 programs initiated in 2021 with readouts expected in 2022 and highlights the robustness of our unique dermatology drug development platform."

08:07 EDT Cortexyme presents data showing P. gingivalis infection in Alzheimer's disease - Cortexyme announced the presentation of new data demonstrating evidence of P. gingivalis infection of the central nervous system in Alzheimer's disease at the Annual Biomarkers for Alzheimer's Disease Summit taking place virtually on Wednesday, August 25. In a featured speaker presentation titled "Use of Novel Biomarkers of P. Gingivalis Infection & Neuroinflammation in the GAIN Trial: An Ongoing Phase 2/3 Clinical Trial Assessing the Activity of Atuzaginstat in Patients with Mild to Moderate Alzheimer's Disease," Cortexyme's executive VP of research and development Leslie Holsinger will present an analysis of anti-P. gingivalis antibodies in cerebrospinal fluid (CSF) with results demonstrating that: All patients analyzed at baseline in the GAIN Trial were positive for anti-P. gingivalis antibodies, or IgG, in their cerebrospinal fluid; Less than 2% of patients analyzed had a leaky blood brain barrier, as defined by an albumin index greater than nine and Anti-P. gingivalis IgG in the CSF was only very weakly correlated to the albumin index, indicating production in the central nervous system in addition to that shown previously in serum. These data add to the growing body of evidence indicating the presence of a P. gingivalis infection within the central nervous system in patients with Alzheimer's disease. Cortexyme will also present other novel biomarkers developed to track markers of P. gingivalis and Alzheimer's disease, in addition to highlighting the upstream role that P. gingivalis plays in key pathologies of Alzheimer's disease progression.

08:07 EDT Hall of Fame Resort & Entertainment CEO buys 20K shares of common stock - In a regulatory filing, Hall of Fame Resort & Entertainment disclosed that its CEO Michael Anthony Crawford bought 20K shares of common stock on August 24th in a total transaction size of $57.8K.

08:05 EDT CytoDyn's announces an update from its Phase 1b/2 trials - CytoDyn announced an update to previously reported preliminary results from its Phase 1b/2 trials and compassionate use with leronlimab to treat a total of 30 metastatic triple-negative breast cancer patients. Decrease in Circulating Tumor Cells as reported using the LifeTracDx test developed by Creatv MicroTech, after induction with leronlimab was associated with a 400%-660% increase in mPFS /12-month PFS and a 570%-980% increase in mOS /12-month OS. Decreases in CTC after leronlimab induction were seen in 73% of the 30 patients in the study. LifeTracDx appears to aid as a parallel diagnostic tool in identifying patients that respond to leronlimab. Data from these 30 patients are aligned with the premise that a majority of mTNBC patients respond to leronlimab if CTC reduction is observed following one leronlimab dose. Scott Kelly, M.D., CytoDyn's Chief Medical Officer and Chairman of the Board, commented, "We are delighted with the results of both mPFS and mOS when compared to the Standard of Care treatment for mTNBC across Emergency Use, Compassionate Use, mTNBC, and our Basket Trial. We anticipate the demand for new therapeutic options with limited toxicity and enhanced convenience for the patient to grow exponentially over the next decade. We believe this is further evidence that leronlimab has a promising role in the future of oncology to help alleviate the burden of cancer on patients and their loved ones. We are exploring opportunities to enhance our oncology platform through pharmacological partnerships, academic partnerships, and research on combining synergistic benefits of leronlimab in the tumor microenvironment."

08:04 EDT Meredith Forrester to join Synovus as new Chief Audit Executive - Synovus Financial announced the appointment of Meredith Forrester as executive vice president and chief audit executive, effective September 8. She was most recently business, strategy and operations leader at Truist, following more than 15 years of leadership in risk management and audit at SunTrust. Forrester succeeds Steve Sawyer, who will retire after 41 years of service, including 18 years as chief executive auditor. "Meredith is a highly experienced audit and risk management executive, with a strong record of leading transformational initiatives and high-performing teams," said Kevin Blair, president and CEO of Synovus. "Under Steve's leadership, and in conjunction with the Audit Committee of the Board of Directors, Synovus has built a robust and independent audit function, and we couldn't be more excited for Meredith to build on Steve's great work. We are so grateful to Steve for four decades of quiet and steady service, and we congratulate him on a well-earned retirement." Forrester joined SunTrust in 2000 and was appointed managing director, internal audit, in 2011; senior managing director, internal audit, in 2015; and deputy general auditor in 2019. Following the merger of SunTrust and BB&T, she was named business, strategy and operations leader at Truist, where she functioned as chief operating and administrative officer for Legal, HR, and Inclusion and Diversity. Forrester earned a bachelor's degree in business administration from the University of Georgia and an MBA from Georgia State University.

08:04 EDT Nexstar, SportsGrid announce multi-year agreement to launch SportsGrid Network - Nexstar Media, a wholly-owned subsidiary of Nexstar, and SportsGrid announced a multi-year agreement to launch SportsGrid Network, the nation's first-ever diginet devoted to sports wagering and fantasy sports. Beginning September 1, SportsGrid Network will be distributed across nine digital subchannels licensed to Nexstar in nine major U.S. markets, including San Francisco, Washington, D.C., Tampa, Portland, Nashville, Norfolk, Grand Rapids, Knoxville, and Des Moines. SportsGrid is the nation's first and only 24-hour sports wagering and fantasy sports program service. SportsGrid's content is currently distributed across over-the-air broadcast and cable television, connected Smart TVs, a variety of streaming platforms, mobile devices and on the internet. The new network will be available on recently vacated digital sub-channels licensed to Nexstar. At its launch, SportsGrid Network will feature 18 hours of exclusive live original programming hosted by a team of on-air personalities, sports and gambling experts, and guest contributors, as well as a variety of pre-produced programming and encore presentations of the network's most popular shows. The network's mission is to provide real-time sports news, data, analytics, and statistics to engage sports audiences whenever and wherever they choose. SportsGrid's reporting and analytic platform includes daily odds, lines, matchups, injury reports, statistics, news, and more across the NFL, NBA, MLB, NHL, college sports, golf, tennis, and soccer. SportsGrid's live programming originates from television production facilities adjacent to Madison Square Garden in New York City and at the SG Studios & Production Hub in New Jersey.

08:04 EDT Rave Restaurant's Pizza Inn signs multi-unit franchise agreement in Palestine - Pizza Inn announced it has executed an international development agreement with Principal Partners Ziad Suwan and Ibrahim Sawan of Z.I.S. General Trading Company, who will open three new locations in Palestine. The first store is projected to open in the city of Ramallah / Nablus in March of 2022. The three-year development agreement includes an option to open additional stores in new locations.

07:57 EDT Imperial Oil to produce renewable diesel in Canada to help reduce emissions - Exxon Mobil (XOM) announced its majority-owned affiliate, Imperial Oil (IMO), is moving forward with plans to produce renewable diesel at a new complex at its Strathcona refinery in Edmonton, Canada. When construction is complete, the refinery is expected to produce approximately 20,000 barrels per day of renewable diesel, which could reduce emissions in the Canadian transportation sector by about 3M metric tons per year. The complex will utilize locally grown plant-based feedstock and hydrogen with carbon capture and storage as part of the manufacturing process. The renewable diesel production process will utilize blue hydrogen, which is produced from natural gas with carbon capture and storage. Production of blue hydrogen has been shown to have substantially reduced greenhouse gas emissions compared to conventionally produced hydrogen. Approximately 500,000 metric tons of CO2 are expected to be captured each year utilizing CCS. The blue hydrogen and biofeedstock will be combined with a proprietary catalyst to produce premium low-carbon diesel fuel.

07:47 EDT Mercado Livre acquires Kangu, terms not disclosed - Mercado Livre has announced its acquisition of Kangu, a Brazilian logistics company that operates in Brazil, Colombia and Mexico. Mercado Livre, which was already a strategic partner, expanded its participation with the acquisition of the entire company. This is consistent with the platform's strategy of increasing investment across its logistics network to boost efficiency for sellers and offer its thousands of customers the fastest delivery times in Brazil. Over 40 thousand sellers currently use the Kangu network in the three countries where it operates. Kangu has more than 5,000 collection and delivery points, more than half of them in Brazil. The company serves a wide variety of companies including Mercado Livre, connecting e-commerce sellers to its network of neighborhood partners such as pet shops, stationers and other local stores. These stores form a high capillarity network of collection points where sellers can leave their products for delivery, or delivery points where customers can pick up their orders. In 2020, Kangu's revenues grew by a factor of 100 year on year. In addition to its pick-up and drop-off points, the company's business model includes shipping services supported by external partners and reverse logistics. Kangu has been able to optimize deliveries and offer additional services thanks to its investment in technology, especially intelligent data management. Kangu will remain independent and will continue to be managed by its co-CEOs. It will continue its strategy of attracting new e-commerce sellers who require efficient collection, delivery and reverse logistics solutions. The Kangu acquisition will reinforce Mercado Livre's business ecosystem as part of its strategy which involves the provision of services from third-party logistics companies, reducing delivery times and expanding capacity at Mercado Envios, its logistics arm. This business unit shipped over 230.5 million items in the second quarter, up 46.4% from Q2 2020. The transaction is subject to approval from competition regulators.

07:44 EDT Ameresco expands higher education presence, teams with Tarleton State University - Ameresco announced its energy savings performance contract, ESPC, with Tarleton State University to develop an energy and water conservation project. The resulting project will enhance campus conditions, promote overall sustainability and improve the reliability and quality of facility operations. instrumentation improvements and HVAC lifecycle replacements. All solutions selected were chosen specifically to address the immediate needs of the university and to reduce Tarleton State's electricity use and natural gas consumption by 21-23% each year. The project will be entirely self-funded using the utility savings generated by the conservation measures implemented, which will also result in a nearly 33% reduction in annual water and wastewater consumption by the university. As part of the ESPC, Ameresco will guarantee the water and wastewater savings amassed throughout the contract. "Our goal is to reduce our deferred maintenance backlog and improve campus operations in a budget neutral manner. After a thorough review process, we couldn't be more thrilled to partner with an organization as committed to advancing the future of sustainability as Ameresco," said Tarleton's Chief Financial Officer Lori Beaty. "Our partnership with the team only furthers our energy and water conservation efforts, which have already seen tremendous success. We cannot wait to see how Ameresco's innovative solutions will continue to transform our campus landscape."

07:36 EDT Dick's Sporting announces special dividend of $5.50 per share - The company announces enhancements to its 2021 capital allocation plan, including a special dividend of $5.50 per share, a 21% increase in its quarterly dividend to 43.75c per share and an increase in its planned share repurchases to a minimum of $400M, an increase of $200M from prior guidance. "This additional cash return to our shareholders demonstrates the confidence we have in our business, the strength of our balance sheet and a commitment to efficiently deploy our cash," said Lauren Hobart, President and CEO. "We continue to remain firmly committed to investing in the profitable growth of our core business." Both the special and regular quarterly dividends are payable in cash on September 24 to stockholders of record at the close of business on September 10.

07:33 EDT Flexion expands Phase 1b trial of FX301 for management of post-operative pain - Flexion Therapeutics announced the expansion of the Phase 1b randomized, double-blind, placebo-controlled trial of FX301 in patients undergoing bunionectomy. FX301 is a novel formulation of a locally administered NaV1.7 inhibitor which aims to provide at least three to five days of post-operative pain relief while preserving motor function. The company's decision to advance FX301 into the expansion cohort follows a review of safety data from the single ascending dose stage of the trial by an independent Safety Monitoring Committee. Subsequently, an internal review committee assessed safety, systemic exposure and efficacy data and made the decision to advance the program. The single ascending dose stage of the Phase 1b trial was designed to evaluate the safety and tolerability of four dosing cohorts of 12 patients each. In the expansion cohort, an additional 36 patients will be randomized to receive either FX301 at the selected dose or placebo to further assess the safety, tolerability, systemic exposure, and efficacy of FX301 as a single-injection analgesic nerve block adjacent to the sciatic nerve of the popliteal fossa.

07:33 EDT Axon acquires anonymous community feedback solution My90 - Axon has acquired My90, which collects anonymized community feedback to generate actionable insights to help police agencies improve trust, safety and equity. Kona Shen and Mustafa Abdul-Hamid founded My90 in 2016 to give communities a secure line of feedback to public safety agencies that could foster community trust and understanding. Since 2016, My90 expanded its services to help individual officers deliver anonymous feedback to department leadership. My90 maintains privacy and anonymity when displaying results via interactive dashboards, which will now be available on the Axon Network. Shen will be joining Axon as VP and General Manager of My90. The terms of the transaction were not disclosed.

07:15 EDT Malibu Boats selects Garmin International to outfit wakesurf, wakeboarding boats - Garmin International, Inc., a unit of Garmin (GRMN), announced that Malibu Boats (MBUU) has selected Garmin to exclusively outfit its full line of Axis Wake Research wakesurf and wakeboarding boats with a customized seven-inch touchscreen display beginning model year 2022.

07:09 EDT Verano Holdings to open MUV Dispensary in Orange City, Florida - Verano Holdings announced the opening of a new MundefinedV Dispensary located at 2494 Enterprise Road in Orange City, Florida. At 10:00 AM, the dispensary will open and begin serving patients, with a planned grand opening to follow on Friday, August 27th at 10:00 AM local time.

07:07 EDT Agra Ventures announces details of share consolidation - Agra Ventures announces that pursuant to a director's resolution AGRA will be consolidating all of its issued and outstanding share capital on the basis of one post-consolidation share for each one hundred and fifty pre-consolidation common shares of the Company. No fractional shares will be issued by AGRA under the Consolidation and any fraction will be rounded to the nearest whole number. As a result, the outstanding common shares of the Company will be reduced to approximately 12,986,374. The exercise or conversion price and the number of common shares issuable under any of AGRA's outstanding convertible securities will be proportionately adjusted upon consolidation. In connection with the Consolidation, the name of the Company will not change and its trading symbol will remain as "AGRA". The Company's common shares are expected to begin trading on a consolidated basis and with a new CUSIP number of 008505208 and a new ISIN number of CA0085052086 on or about August 27, 2021.

07:06 EDT NSSLGlobal, Telesat announce strategic cooperation agreement for LEO Network - NSSLGlobal and Telesat have signed a long-term strategic co-operation agreement to collaborate on the commercial and technical aspects of Telesat's new Low Earth Orbit constellation, Telesat Lightspeed, initially consisting of a global mesh network of 298 state-of the-art LEO satellites that are seamlessly integrated with on-ground data networks. Telesat Lightspeed will be the world's most advanced LEO network, optimized to serve the critical connectivity requirements of enterprise, government and mobility customers. The agreement will include the integration of Telesat Lightspeed services into NSSLGlobal's value-added network, providing an expanded service portfolio that delivers increased performance, flexibility and resiliency for customers. As a key commercial launch partner, NSSLGlobal will provide a European end-user testing and trials facility for Telesat Lightspeed services at its UK Headquarters. From this facility, NSSLGlobal will support Telesat with service testing, performance validation and customer onboarding to the Telesat Lightspeed network, and also conduct field testing of user terminals from a range of providers. NSSLGlobal intends to market Telesat Lightspeed services into the European Defence and Maritime markets.

07:05 EDT iClick Interactive Asia raises share repurchase authorization to $25M - The company said, "We are increasing our share repurchase program from $15 million to $25 million as we remain highly confident of our long-term growth prospects despite short-term headwinds."

07:04 EDT CTI BioPharma and DRI Healthcare Trust enter funding transaction for up to $135M - CTI BioPharma and DRI Healthcare Trust announced transactions totaling up to $135M in funding for CTI, with $50M in secured debt to be funded at closing and $60M to purchase a tiered royalty on sales of pacrinitib upon product approval of pacrinitib by the FDA. The proceeds of the transactions will be used by CTI to fund the commercialization of pacritinib for the treatment of myelofibrosis patients with severe thrombocytopenia. CTI has a New Drug Application under priority review by FDA with a PDUFA target action date of November 30, and is preparing for a potential commercial launch by end of year. DRI Healthcare will provide a $50M credit facility at closing. The credit facility bears interest at LIBOR + 8.25% and is interest-only for the loan term of 5 years, with the outstanding principal due at maturity. The company will be subject to one financial covenant, which is maintaining minimum liquidity of at least $10M during the term of the loan. DRI Healthcare will also provide CTI with $60M upon receiving accelerated approval of pactritinib, and will receive royalties on annual pacrinitib net sales in the U.S. of 9.6% for the first $125M of annual U.S. net sales, 4.5% between $125M and $175M of annual U.S. net sales, 0.5 % between $175M and $400M of annual U.S. net sales, with no entitlement above $400M of annual U.S. net sales. CTI will be entitled up to an additional $25M on achievement of certain sales milestones.

07:03 EDT BridgeBio, LianBio announce first patient treated in infigratinib trial - LianBio and BridgeBio announced the first patient has been treated in a Phase 2a clinical trial of infigratinib in patients with locally advanced or metastatic gastric cancer or gastroesophageal junction adenocarcinoma with fibroblast growth factor receptor-2 gene amplification and other advanced solid tumors with FGFR genomic alterations.

07:02 EDT Helius Medical announces voluntary de-listing from Toronto Stock Exchange - Helius Medical Technologies announced that it has provided written notice to the Toronto Stock Exchange regarding the voluntary delisting of its Class A common stock from the TSX. The Company believes that the trading volume of its shares on the TSX no longer justifies the expense and administrative efforts associated with maintaining this listing, especially given Helius' listing on The Nasdaq Capital Market. The Company's listing on Nasdaq provides its stockholders with good liquidity, and the savings in exchange fees, legal fees and managerial time and effort to maintain a dual listing can be redirected into further advancing the business of the Company. Helius anticipates that its Class A common stock will be delisted from the TSX at the close of trading on or about September 9, 2021. Pursuant to Section 720(b)(i) of the TSX Company Manual, shareholder approval is not required with regards to the voluntary delisting as an alternative market for the shares will exist on Nasdaq. Stockholders holding shares in Canadian brokerage accounts should contact their brokers to confirm how to trade Helius' shares on the Nasdaq.

06:54 EDT Eagle Pharmaceuticals signs global licensing agreement with Combioxin for CAL02 - Eagle Pharmaceuticals has entered into a worldwide licensing agreement with Combioxin, a clinical-stage biotechnology company based in Epalinges, Switzerland, for the commercial rights to CAL02, a novel first-in-class antitoxin agent ready for Phase 2b/3 development for the treatment of severe pneumonia in combination with traditional antibacterial drugs. Eagle will be solely responsible for further clinical development of CAL02 and will make an upfront payment, followed by additional payments upon achievement of development milestones, regulatory approval and based upon commercial sales. Eagle expects to invest $35M to achieve interim results. These interim results are expected in the first half of 2023. CAL02 is designed to be an add-on therapy to antibiotics to neutralize virulence effectors. The first-in-human clinical trial results show a favorable safety profile when administered in combination with standard antibiotics to patients with severe community-acquired bacterial pneumonia hospitalized in the intensive care unit. Patients treated with CAL02 presented a faster clinical improvement. Eagle anticipates ten years of regulatory exclusivity. The company plans to advance the clinical program and initiate a Phase 2b/3 study in the first half of 2022.

06:51 EDT Velodyne Lidar announces multi-year sales agreement with Renu Robotics - Velodyne Lidar announced a multi-year agreement to provide its Puck lidar sensors to Renu Robotics, an industry leader in autonomous vegetation management systems. Renu Robotics' Renubot, a fully autonomous, all-electric mower, helps solar and energy facilities cut costs, time and carbon emissions, while maintaining the grounds for maximum performance of the facility.

06:49 EDT Rocket Lab USA completes merger with Vector Acquisition - Rocket Lab USA (RKLB) announced that it completed its previously announced merger with Vector Acquisition Corporation (VACQ) to take Rocket Lab public. Vector's shareholders approved the merger at an annual general meeting of Vector's shareholders on August 20. The combined company will retain the Rocket Lab USA name and will commence trading on the Nasdaq Capital Market on August 25 with its common stock and warrants trading under the new ticker symbols, "RKLB" and "RKLBW", respectively.

06:47 EDT LyondellBasell CEO Bhavesh Patel to retire at end of year - LyondellBasell announced that CEO Bhavesh Patel intends to retire from the company as of December 31. Patel will continue to lead the company until that time and will ensure a transition for his successor. Upon his departure, he will also resign from the company's board of directors. The board of directors has established a sub-committee that will oversee the search for a new CEO and will consider both internal and external candidates.

06:36 EDT Lipocine announces LiFT study meets primary endpoint - Lipocine announced topline 36-week results from its Phase 2 proof of concept LiFT clinical study, investigating LPCN 1144 in men with biopsy-confirmed NASH. Currently, there are no approved treatments for NASH, a cause of liver failure and liver transplantation globally. LPCN 1144 comprises an orally delivered prodrug of endogenous testosterone, or T. The LiFT clinical study, a prospective, multi-center, randomized, double-blind, placebo-controlled, multi-arm, multi-site trial in the United States, enrolled biopsy-confirmed hypogonadal or eugonadal male NASH subjects with stage F1-F3 fibrosis and a NAFLD Activity Score of 4 for a 36-week treatment period. Subjects with advanced fibrosis and steatohepatitis were also eligible. Subjects were randomized 1:1:1 to one of three arms. The primary endpoint of the LiFT clinical study was change in hepatic fat fraction via MRI-PDFF post 12 weeks of treatment. Additionally, key secondary endpoints post 36 weeks of treatment include assessment of histological change for NASH resolution and/or fibrosis improvement. The LiFT clinical study was not powered to assess statistical significance of any of the secondary endpoints. At 12 weeks, treatments with LPCN 1144 resulted in statistically significant liver fat reduction, assessed by MRI-PDFF, meeting the pre-specific primary endpoint of the LiFT clinical study. Statistically significant reduction in liver fat was observed compared to placebo: up to a mean of 9.2% absolute reduction and a 46.8% relative reduction in liver fat. Liver biopsies were performed at baseline and after 36 weeks of treatment. Prespecified biopsy analyses include NASH Clinical Research Network scoring as well as a continuous paired and digital technique. All biopsy analyses were performed on the same slides and the reads for the three techniques were done independently. Analysis sets included the NASH Resolution Set (all subjects that have BL and EOS biopsy with NASH at BL, the Biopsy Set, and the Safety Set. Both LPCN 1144 treatment arms met with statistical significance the pre-specified accelerated approval regulatory endpoint of NASH resolution with no worsening of fibrosis based on NASH CRN scoring. Additionally, both treatment arms showed substantial improvement of the observed NASH activity in steatosis, inflammation and ballooning. Both LPCN 1144 treatment arms showed significant improvement in NASH without worsening of fibrosis using Paired Technique, which concurred with the NASH CRN scoring findings. The treatment effects on fibrosis improvement need confirmation in a larger study. In both treatment arms substantial reductions in markers of liver injury compared to placebo were observed post four weeks of treatment and were sustained through EOS. Using all available Safety Set data, alanine aminotransferase decreased up to a mean of 23.4 U/L at EOS from all group mean baseline of 51.5 U/L and aspartate aminotransferase decreased up to a mean of 13.3 U/L at EOS from all group mean baseline of 31.9 U/L. Positive effects in appendicular lean mass and whole-body fat mass, an indicator overall tissue quality, based on dual-energy X-ray absorptiometry scans were noted in both LPCN 1144 treatment arms. During the 36 weeks of treatment, LPCN 1144 was well tolerated with an overall safety profile comparable to placebo. Frequency and severity of treatment emergent adverse events, TEAEs, in both treatment arms were comparable to placebo. Study drug related TEAEs were mild to moderate. Four subjects discontinued due to TEAEs in the placebo arm vs one subject in total across the treatment arms. Cardiovascular events were balanced among groups with hematocrit increases averaging less than 2% in the treatment arms, no observed thromboembolic events, and comparable blood pressure changes in both treatment arms to placebo. There were no reported cases of hepatocellular carcinoma or Drug Induced Liver Injury. Weight change from baseline, GI adverse events and PSA changes were small and comparable among groups. Additionally, no clinically meaningful changes in lipids in treatment groups were noted compared to placebo, and rates of pedal edema were low and similar in all arms. Additionally, all subjects had the option to continue with LPCN 1144 treatment through an open label extension study. The extension study will enable the collection of additional data on LPCN 1144 for up to a total of 72 weeks of therapy.

06:32 EDT Emergent BioSolutions to initiate trial of COVID-HIG product candidate - Emergent BioSolutions announced the initiation of a Phase 3 clinical trial that will evaluate its investigational SARS-CoV-2 Immune Globulin Intravenous plasma-derived therapy as a potential outpatient treatment for patients with coronavirus disease that are at high risk of progression to severe disease, including adults 55 and older and those 18 and older who are immunocompromised. The INSIGHT-012 clinical study called "Outpatient Treatment with Anti-Coronavirus Immunoglobulin" is sponsored by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. The study will evaluate the safety and efficacy of hyperimmune globulin products derived from plasma of individuals who have recovered from COVID-19 and have developed neutralizing antibodies to SARS-CoV-2, the virus that causes COVID-19. The randomized controlled clinical trial assigns participants to receive infusions of either a placebo or one of two hyperimmune globulin products, including Emergent's COVID-HIG, in addition to standard of care in all groups.

06:29 EDT Cathie Wood's ARK Investment bought 529K shares of Fate Therapeutics on Tuesday

06:17 EDT Locust Walk Acquisition stockholders approve combination with eFFECTOR - Locust Walk Acquisition "announced that the company's stockholders have approved all proposals related to the previously announced business combination with eFFECTOR Therapeutics at a special meeting of stockholders held on August 24, 2021. Approximately 93.2% of the votes cast at the meeting on the Business Combination proposal, representing approximately 71.7% of LWAC's outstanding shares, voted to approve the Business Combination. The Business Combination is expected to close on or about Wednesday, August 25, 2021. Upon closing, the combined company expects that its common stock and public warrants will commence trading on Nasdaq under the new trading symbols "EFTR" and "EFTRW," respectively, starting on or about Thursday, August 26, 2021. eFFECTOR expects that the net cash following the transaction will allow it to readout topline data from the ongoing Phase 2b KICKSTART trial evaluating tomivosertib in combination with pembrolizumab in patients with metastatic non-small cell lung cancer, as well as readout initial overall response rate data from the ongoing Phase 2a dose expansion cohorts evaluating zotatifin in patients with certain biomarker-positive solid tumors, including ER+ breast cancer and KRAS-mutant NSCLC."

06:10 EDT Royal Bank of Canada reports Q3 ROE of 19.6%, up 15.7% y/y - Reports CET1 Ratio 13.6%, well above regulatory requirements.

06:08 EDT Cassava Sciences responds to allegations regarding scientific integrity - Cassava Sciences issued a response to claims that were posted on-line yesterday after market hours. Cassava Sciences believes the claims made in this post regarding scientific integrity are false and misleading. The company stands behind its science, its scientists and its scientific collaborators, and is responding to ensure the facts are known and respected. "As a science company, we champion facts that can be evaluated and verified," said Remi Barbier, President & CEO. "This helps people make informed choices. It is important for stakeholders to separate fact from fiction, which is why we wish to address allegations head-on."

06:06 EDT Armada Hoffler acquires Overlook Village and Greenbrier Square - Armada Hoffler has completed the off-market acquisition of two retail centers; Overlook Village in Asheville, North Carolina for $28.35M and Greenbrier Square in Chesapeake, Virginia for $36.5M. Currently, Overlook Village is 100% occupied, while Greenbrier Square is 95.4% occupied with one value-add opportunity. Overlook Village is located in the area of Asheville and anchored by T.J.Maxx, HomeGoods, Ross Dress for Less, and Five Below. Greenbrier Square is a retail center completed in July 2017 in the Chesapeake area. Kroger Marketplace, the anchor tenant, is the most visited Kroger in the state of Virginia.

06:04 EDT OneConnect signs MOU to purchase majority stake in credit technology company - OneConnect has entered into a Memorandum of Understanding to acquire a majority equity stake in Shenzhen Vzoom Credit Technology, a credit technology company that provides integrated credit solutions to help financial institutions in China automate, transform and scale up credit products and services for medium and smalls enterprises. OneConnect intends to acquire no less than 50% equity stake in Vzoom Credit Technology in exchange for a combination of cash and shares. The exact valuation, the percentage of equity stake to be sold, and the form of consideration for the acquisition will be provided for in a definitive agreement. The closing of the transaction is subject to the execution of the definitive agreement, OneConnect's satisfactory due diligence and internal approval as well as any other conditions to be identified in the definitive agreement. The MOU provides an exclusivity of three months from its date.

05:13 EDT XPeng starts shipping first batch of XPeng P7 smart sedans to Norway - XPeng started shipping the first batch of the XPeng P7, its flagship smart sedan model, from Guangzhou to Norway. This marks the first time that XPeng has exported the P7 to a market outside China. The P7 is XPeng's second production model for the Norwegian market, following the delivery of the G3 smart SUV to customers in Norway in December 2020. Following its launch in China in mid-2020, over 40,000 P7s have been delivered to Chinese customers as of end July. The localized Norwegian version of the P7 rolled off XPeng's production line at its Zhaoqing Smart EV Manufacturing Base in August. The first Norwegian customers are expected to receive their P7s in Q4.